© Getty Images

Vaxess announces $9 million in funding for mRNA vaccine patch

By Isabel Cameron

Vaxess Technologies, a life sciences company developing a shelf-stable vaccine patch with potential for self-application, has announced an additional $9 million in venture capital funding, with investors including RA Capital, The Engine, and GHIC, and...

© Getty Images

Kuano raises £1.8 million to accelerate quantum drug discovery

By Isabel Cameron

Kuano, a drug discovery company combining quantum mechanics with AI, has announced the close of its £1.8 million seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP, and other...


Follow us


View more


Featured Suppliers